The overall 5-year survival rate of stage IV rectal cancer is 5%~10%, and the specific survival rate is related to individual patient’s condition, whether he/she cooperates with the treatment, pathological type, genetic type, treatment method and whether he/she cooperates with the treatment.
Stage IV rectal cancer means that the malignant tumor has spread to other organs and lymphatic tissues, and distant metastasis has occurred. Five-year survival rate is commonly used in clinical practice to roughly assess the survival of patients suffering from certain malignant tumors, and the overall five-year survival rate of stage IV rectal cancer, i.e. advanced stage, is 5%~10%, and the five-year survival rate of surgically resectable tumors is 31%~42%, which varies according to the type of tumors, different geographic regions and other factors. The data varies according to tumor type, different regions and other factors.
At present, stage IV rectal cancer can be treated with palliative surgery, chemotherapy, radiotherapy, targeted therapy and other treatment modalities. According to individual conditions and other auxiliary examinations, choosing suitable treatment plan can prolong the survival period of patients, and it is recommended that patients diagnosed with stage IV rectal cancer should go to the oncology department of regular hospitals in a timely manner to consult and cooperate with physicians for treatment.